US6956032B1
(en)
*
|
1986-04-18 |
2005-10-18 |
Carnegie Mellon University |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
|
US5676648A
(en)
|
1996-05-08 |
1997-10-14 |
The Aps Organization, Llp |
Iontophoretic drug delivery apparatus and method for use
|
US6385487B1
(en)
|
1996-05-08 |
2002-05-07 |
Biophoretic Therapeutic Systems, Llc |
Methods for electrokinetic delivery of medicaments
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
WO1998018417A1
(en)
*
|
1996-10-30 |
1998-05-07 |
Theratech, Inc. |
Fatty acid esters of lactic acid salts as permeation enhancers
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
USRE37796E1
(en)
|
1997-12-16 |
2002-07-23 |
Biophoretic Therapeutic Systems, Llc |
Methods for iontophoretic delivery of antiviral agents
|
WO1999032153A1
(en)
*
|
1997-12-22 |
1999-07-01 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
AU759641B2
(en)
*
|
1998-08-19 |
2003-04-17 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
US6148231A
(en)
*
|
1998-09-15 |
2000-11-14 |
Biophoretic Therapeutic Systems, Llc |
Iontophoretic drug delivery electrodes and method
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7127285B2
(en)
*
|
1999-03-12 |
2006-10-24 |
Transport Pharmaceuticals Inc. |
Systems and methods for electrokinetic delivery of a substance
|
US6477410B1
(en)
|
2000-05-31 |
2002-11-05 |
Biophoretic Therapeutic Systems, Llc |
Electrokinetic delivery of medicaments
|
US6792306B2
(en)
*
|
2000-03-10 |
2004-09-14 |
Biophoretic Therapeutic Systems, Llc |
Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
|
DE19918105C1
(de)
*
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
ES2309107T3
(es)
*
|
2000-10-23 |
2008-12-16 |
Euro-Celtique S.A. |
Dispositivo y metodos transdermicos para felodipina.
|
US7018649B2
(en)
|
2000-10-23 |
2006-03-28 |
Euro-Celtique, S.A. |
Felodipine transdermal device and methods
|
PL363079A1
(en)
*
|
2001-03-16 |
2004-11-15 |
Alza Corporation |
Transdermal patch for administering fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
US20030153590A1
(en)
*
|
2001-08-14 |
2003-08-14 |
Oy Contral Pharma Ltd |
Method of treating alcoholism or alcohol abuse
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
WO2003090729A1
(en)
*
|
2002-04-23 |
2003-11-06 |
Alza Corporation |
Transdermal analgesic systems with reduced abuse potential
|
CA2488915C
(en)
|
2002-06-10 |
2011-10-04 |
Euro-Celtique S.A. |
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
|
AU2003268144A1
(en)
*
|
2002-08-20 |
2004-03-11 |
Euro-Celtique, S.A. |
Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
|
MXPA05002254A
(es)
*
|
2002-08-30 |
2005-06-08 |
Alza Corp |
Construccion de refuerzo multilaminar estampable y registrable.
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US7323191B2
(en)
|
2003-07-28 |
2008-01-29 |
Alza Corporation |
Transdermal warfarin system
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
EP2269606A3
(de)
*
|
2003-10-30 |
2012-04-25 |
ALZA Corporation |
Transdermale analgesische Systeme mit reduziertem Missbrauchspotential
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
CN100425233C
(zh)
*
|
2005-01-12 |
2008-10-15 |
复旦大学 |
一种鼻腔用尼莫地平凝胶剂
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
WO2006124584A2
(en)
*
|
2005-05-13 |
2006-11-23 |
Alza Corporation |
Multilayer drug delivery system with barrier against reservoir material flow
|
WO2007011763A2
(en)
*
|
2005-07-15 |
2007-01-25 |
3M Innovative Properties Company |
Adhesive sheet and methods of use thereof
|
WO2007010900A1
(ja)
*
|
2005-07-15 |
2007-01-25 |
Transcu Ltd. |
貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
|
US8383149B2
(en)
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US20070098772A1
(en)
*
|
2005-09-23 |
2007-05-03 |
Westcott Tyler D |
Transdermal norelgestromin delivery system
|
US20070134310A1
(en)
*
|
2005-09-23 |
2007-06-14 |
Nedberge Diane E |
Transdermal risperidone delivery system
|
US20070104771A1
(en)
*
|
2005-09-23 |
2007-05-10 |
Jay Audett |
Transdermal galantamine delivery system
|
AU2006299833B2
(en)
|
2005-10-12 |
2012-04-12 |
Besins Healthcare Luxembourg Sarl |
Improved testosterone gel and method of use
|
JP2009522011A
(ja)
|
2005-12-30 |
2009-06-11 |
Tti・エルビュー株式会社 |
活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法
|
MX2008014870A
(es)
|
2006-05-30 |
2009-02-12 |
Intarcia Therapeutics Inc |
Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
EP3421031A1
(de)
|
2006-08-09 |
2019-01-02 |
Intarcia Therapeutics, Inc |
Osmotisches verabreichungssystem mit kolbenanordnung
|
US20080193514A1
(en)
*
|
2006-11-02 |
2008-08-14 |
Transcu Ltd. |
Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
|
WO2008087803A1
(ja)
*
|
2007-01-16 |
2008-07-24 |
Hokkaido University |
抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
|
CN101715340A
(zh)
|
2007-04-23 |
2010-05-26 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
JP2010187707A
(ja)
*
|
2007-06-12 |
2010-09-02 |
Hokkaido Univ |
インスリンを封入したイオントフォレーシス用リポソーム製剤
|
EP2207507B1
(de)
*
|
2007-10-15 |
2018-11-21 |
Alza Corporation |
Einmal tägliche transdermale ersatz-verabreichung von fentanyl
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
CA2736495A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Gregory A. Smith |
Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
|
CN104523661A
(zh)
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
BR112012022209A2
(pt)
|
2010-03-03 |
2017-06-06 |
Neonc Tech Inc |
composições farmacêuticas compreendendo monoterpenos
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2014105480A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Teikoku Pharma Usa, Inc. |
Extended buprenorphine transdermal delivery compositions and methods for using the same
|
EP3146964A4
(de)
*
|
2014-05-20 |
2018-01-10 |
Alcare Co., Ltd. |
Klebmittelzusammensetzung für haut und pflastermaterial für haut
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
CA2977814A1
(en)
|
2015-03-12 |
2016-09-15 |
Chrono Therapeutics Inc. |
Craving input and support system
|
KR102650751B1
(ko)
|
2015-06-03 |
2024-03-22 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
CA3020153A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
SG10201913699QA
(en)
|
2016-05-16 |
2020-03-30 |
Intarcia Therapeutics Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
EP3565617A1
(de)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Vorrichtungen und verfahren zur transdermalen wirkstofffreisetzung
|
JP7325425B2
(ja)
|
2018-02-08 |
2023-08-14 |
ネオンク テクノロジーズ インク. |
血液脳関門を透過性にする方法
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
CN109700601B
(zh)
*
|
2019-02-02 |
2022-04-22 |
天津嘉氏堂科技有限公司 |
一种水胶体硅敷料贴
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|